Henry Schein, Inc. in Denver receives FDA inspection on April 2

Benjamin D. Moncarz Chief Financial Officer - FDA
Benjamin D. Moncarz Chief Financial Officer - FDA
0Comments

The Food and Drug Administration (FDA) conducted an inspection of Henry Schein, Inc. in Denver on April 2, as shown in data posted on the FDA’s website.

The review included the following areas:

  • Food Composition, Standards, Labeling and Econ
  • Foodborne Biological Hazards

The inspection’s closing report stated that Henry Schein, Inc. was not required to implement any corrective actions for its management practices.

The FDA regularly examines facilities nationwide to assess whether workplaces and their products meet FDA-regulated standards and regulations that support public health. Summaries of these inspections are made available to the public.

According to its website, the FDA is a federal agency tasked primarily with overseeing the safety and quality of human and animal drugs, biological items, medical devices and tobacco products.

Information in this article was obtained from the U.S. Food and Drug Administration. The source data can be found here.



Related

Sridhar Mantha, Acting Chief Information Officer of FDA

FDA inspects Central Pennsylvania Blood Bank in Ephrata on March 11

The Central Pennsylvania Blood Bank in Ephrata was inspected by the FDA on March 11 regarding blood and blood product safety, based on information made available on the FDA’s website.

Martin A. Makary, M.D. Commissioner of Food and Drugs of FDA

Companies across Lancaster County cities saw 4 FDA citations in March

There was one company in a city associated with Lancaster County that received FDA citations as a result of one inspection conducted in the county in March, according to reports from the U.S. Food and Drug Administration (FDA).

Jim Traficant, Chief of Staff of FDA

How many companies in cities in Lancaster County received FDA inspections in March?

There were two companies in cities associated with Lancaster County that received two FDA inspections in March, according to the U.S. Food and Drug Administration.